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ABSTrACT                        The normal functions of the cells are based on a strict and regulated expression 
of various genes. If this precise hierarchy of gene actions becomes unregulated or disturbed due 
to different genetic or environmental effects, the result will be abnormal cellular function that 
eventually could lead pathological alterations, including carcinogenic transformation or apop-
tosis. To understand the complex mechanisms and networks involved in biological processes and 
diseases, it is not enough to analyze isolated pathways, single gene functions or a single genetic 
event. A living organism has to be studied as a complex system and all genes involved in differ-
ent biological processes need to be analyzed simultaneously: a systems biology approach should 
be applied. In the beginning of the 1990’s years, a new, high throughput technology - called 
microarray technology – was developed to measure the expression levels of large numbers of 
genes simultaneously or to genotype multiple regions of a genome. Microarrays have dramati-
cally accelerated many types of investigation since a microarray experiment can accomplish many 
genetic tests in parallel. This review summarizes some of aspects of the microarray technology, 
including sample preparations, application possibilities and data analysis.
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introduction
Until the end of the last century, studying gene function and 
regulation was restricted to examination of one or very few 
genes at a time. The different successful genome projects gave 
the opportunity to develop new, high throughput molecular 
methods for gene expression monitoring, mutation analysis of 
the whole genome (single nucleotide polymorphisms (SNP) 
analysis, array-based comparative genomic hybridization 
(CGH), protein expression and gene and protein interaction 
analysis. These novel functional molecular biology technolo-
gies are extraordinary tools to simultaneously monitor differ-
ent mutations in the genome, monitoring all gene activities in 
one experiment, and analyze protein expression differences 
between diverse biological samples in a comparative way 
at different levels: genome, transcriptome or proteome. The 
basic role of functional biology is to identify new genes and 
gene functions, explore new regulatory networks involved in 
different cellular processes.
One of the most powerful and widespread high throughput 
methods is the microarray technology which has become an 
essential tool for a new discipline studying the expression 
of all genes in a genome simultaneously. This technology 
has been applied to a diverse range of studies such as for 
transcriptome analysis, detection and characterization of 
genetic variants (e.g., SNP, copy number variants (CNVs)), 
studying DNA-protein interaction, and detecting genome 
methylation. 
The main innovation of the microarray technology was 
the immobilization of different molecules (oligonucleotides, 
proteins, small drug like compounds) onto a solid and acti-
vated surface. These molecules are bound to these surfaces 
as a matrix in a well-defined order. This high density matrix 
arrangement of biologically active molecules is called mi-
croarray. In one spot of a microarray, high concentration of a 
given molecule is immobilized and can have specific interac-
tion with its target. On one microarray thousands or millions 
of specific spots can be immobilized enabling the analysis of 
a full genome, transcriptome or proteome of an organism at 
a given time point. 
Analysis of nucleic acids: hybridization 
techniques
The quantitative analysis of nucleic acids in an organism, 
tissue or cell is essential if we want to gather information 
about their roles, function and interactions. Almost all the 
techniques that could provide us these data based on one of 
the very important features of the DNA. Namely, the two 
complementary strands of the DNA - following the Watson-
Crick base pairing rule - can complete and hybridize to each 
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other. Although many of the techniques used in nucleic acid 
research are not based on hybridization, this specific feature 
of nucleic acids is an essential base for emerging such high 
throughput technologies like microarray technology. The 
hybridization-based quantitative analysis of nucleic acids 
started with a discovery in 1965 by Gillespie and Spiegelman, 
when they described that not only the denatured DNA strands 
bound to nitrocellulose membrane but a single strand DNA 
could also bind to its immobilized complementary sequence 
(Gillespie et al. 1965). This observation became the basis of 
the detection and analysis of specific DNA sequences using 
labeled single strand DNA or RNA.
Southern in 1975 used 32P isotope to label DNA molecules 
(radioactive labeling) in a special buffer solution. The first 
step in this method is the extraction of DNA or RNA from 
the sample tissues or cells followed by an enzymatic frag-
mentation (using precisely chosen restriction endonuclease 
in the case of DNA) and separation of the nucleic acid by gel 
electrophoresis. The separated nucleic acid fragments are 
then blotted and immobilized onto nitrocellulose or nylon 
membrane (usually baked at 80 °C for a couple of hours for 
nitrocellulose membranes, or using ultraviolet radiation in 
case of nylon membrane). The denatured and labeled single 
stranded DNA molecules find their complementary pairs on 
the nitrocellulose or nylon membrane showing the specific 
interaction as radioactive signal (Southern et al. 1975). The 
labeled single stranded nucleic acid is called probe, while the 
immobilized nucleic acid is called sample. 
This approach was further improved by Kafatos and co-
workers in 1979 (Kafatos et al. 1979). They spotted different 
DNA molecules onto nitrocellulose membrane in a well-
defined order. Since they spotted many different unknown 
DNA molecules onto the surface, many samples could be 
tested in one step during the hybridization. Spots arranged 
on a solid surface in a well-defined order are called arrays. 
Using this so called “dot-blot” technique, the presence of an 
antibiotic resistance gene (labeled probe) can be detected in 
many different plants (their DNA spotted onto solid surface as 
samples) so for example, transgenic plant carrying a marker 
gene can be easily selected. The question that can be answered 
using dot blot technique is the presence of a homologue pair 
of a known nucleic acid sequence in a relatively wide range 
of unknown DNA population. This known nucleic acid frag-
ment can be DNA or RNA molecule.
In the “reverse dot blot” technique the sample and the 
probe are in reverse position. In this case the sample nucleic 
acid extracted from a biological sample is labeled with e.g., 
isotope and the probes (many different sequences) are immo-
bilized on a solid surface one by one. During the hybridization 
step the labeled sample nucleic acid finds its complementary 
probe on the surface. In this case, using the aforementioned 
antibiotic resistance example, the question to be answered 
is how many different resistance genes can be found in a 
given plant. Applying this technique, the presence of many 
genes, sequences can be tested in one experiment. The first 
relatively large reverse dot blot array was made by Saiki and 
coworkers in 1989 (Saiki et al. 1989). They bound synthetic 
oligonucleotides corresponding to different mutant alleles 
of the human HLA gene (human lymphocyte antigen) onto 
a nitrocellulose membrane. This miniature membrane was 
called DNA chip, or gene chip, although the high density 
microarrays used nowadays was developed only eight years 
later at Stanford University. 
The DNA chip technology (or DNA microarray technol-
ogy) is a reverse dot blot technique where the number of 
spotted oligonucleotides with known sequence can vary 
between several thousand to even a hundred thousand. Thus 
this technology is a hybridization based nucleic acid detec-
tion system, where thousands of different genes or nucleotide 
changes can be analyzed in one hybridization step.
Classification and preparation of DNA arrays, 
steps in a microarray experiment
The DNA arrays are usually classified according to the num-
ber of the different DNA molecules immobilized on their 
surfaces (Table 1). Macroarrays contain a few hundred to a 
maximum a thousand gene specific probes. The diameter of 
these spots is bigger than 300 micrometer. This technique was 
used mainly in experiments, where a small number of focused 
gene activities were tested or the presence of a small number 
of nucleic acid molecules wanted to be identified. The spotted 
probes are usually longer (>400 nt) cDNA molecules, or am-
plified and denatured PCR products. Since the sample nucleic 
acids are always radio-labeled, the quantity of the bound DNA 
is determined by autoradiography. The preparation of these 













Microarray 1000-200000 80-300 cDNA, PCR product, 
oligonucleotide
>50 activated glass spotted (printing robot, 
inkjet) or in situ synthesis
Table 1. Comparison of macro- and microarrays.
53
Microarray technology
arrays does not require automated chip printer (printer robots) 
and sophisticated data analyzing system. 
In contrast, microarrays have several thousand or a hun-
dred thousand of spotted probes on their surface with a less 
than 300 μm in diameter. During microarray preparation, high 
precision and computer driven automated printing robot spots 
the DNA fragments onto the surface of chemically activated 
glass microscope slides (or in some cases a flexible nitrocel-
lulose membrane can also be used). The printer head contains 
4-48 precisely shaped pins with a thin capillary tunnel inside. 
All the pins suck the DNA solution by capillary action and put 
a micro spot (few nanoliter in volume) onto the surface. The 
diameter of the spot is determined by the capillary force and 
the surface tension. It usually means an approximately 80-300 
micrometers in diameter and about 1-5 nanoliters solution 
regarding one spot. The microarrays contain longer cDNA 
fragments or shorter synthetic oligonucleotides in very high 
density. If electric current is applied, the ink-jet technology 
drops standard size spots onto the surface without actually 
touching the surface resulting uniform spot morphology. The 
reason this technology has not been spread widely for spotting 
pre-synthesized oligonucleotides is the high reagents neces-
sity. However, when active precursors (phosphoramidites) are 
spotted, ink-jet technology results in highly precise deposition 
and high density microarrays.
Although the cDNA based arrays were more common in 
the early years, due to problems with annotation and clone 
identification, synthetic oligonucleotide (50–70-mer) plat-
forms became more popular (Woo et al. 2004). Comparative 
studies showed that oligonucleotide arrays offer several 
advantages over cDNA platforms in terms of specificity, 
sensitivity, and reproducibility (Hughes et al. 2001). The glass 
surface in the case of cDNA fragment is usually treated with 
aminosilane or polylysine (amine groups on the surface) and 
ionic bond immobilizes the DNA onto the surface. In contrast, 
the synthetized oligonucleotides usually amino modified. 
When preparing oligonucleotide microarrays, there are active 
groups on the surface and the oligonucleotides are covalently 
bound onto the surface.
Besides the spotting techniques mentioned earlier (printer 
robots, ink-jet technology), oligonucleotides can be immo-
bilized onto the surface by in situ oligonucleotide synthesis 
using special chemical solutions. Oligonucleotide based mi-
croarrays prepared by in situ synthesis are called DNA chips 
or gene chips. In these cases, the oligonucleotides are not 
prepared in advance and bound to the surface, but synthesized 
in situ onto the solid surface instead. The basic technology 
which was developed by the Affymetrix Inc. (www.affyme-
trix.com) is based on photolithography (Lockhart et al. 1996). 
The key element of the innovation was the development of a 
photosensitive protective group. The bound protective group 
inactivates the nucleotide, but after UV light exposure, the 
photosensitive group dissociates and the nucleotides become 
active. The whole surface of the chip is covered by a series of 
a computer designed and very precisely perforated masks. All 
these masks have a specific perforation pattern. After putting 
one mask on, UV light dissociates the protection groups in 
the affected spots. For example, if activated thymine (T) is 
added to the system with the appropriate coupling buffers, the 
first nucleotide will be T and the application of further perfo-
rated masks will determine the place of the next nucleotides. 
Since the newly bound nucleotides also contain the protective 
group, the process is continuous. To build a 25-mer oligo-
nucleotide, 4 x 25 = 100 synthesis steps are necessary. The 
same chemistry is used for a more modern technology, where 
perforated masks are not necessary, because the photosensi-
tive protection groups are dissociated by light directed with 
digitally controlled micro-mirror system (www.nimblegen.
com). Using this technology, preparation of custom DNA 
chips is quicker and more economic. 
A microarray experiment typically requires a (i) DNA 
microarray, (ii) labeled nucleic acids (RNA or DNA) from 
the tissue or cells of interest, (iii) proper hybridization en-
vironment, (iv) laser scanner to detect fluorescent signal, 
and (v) computer and software background (bioinformatics 
background) for data analysis and to properly interpret results. 
Some basic information about the DNA chips have already 
discussed in this review. Now we summarize some of the 
aspects of the other four key steps. 
Labeling strategies, hybridization
The most wildly applied method to obtain labeled sample – if 
gene expression is in the focus of the study - is to convert the 
RNA to cDNA. During reverse transcription (RT), the whole 
RNA in the sample is reverse transcribed to cDNA with the 
help of reverse transcriptase enzyme. One option is to add 
fluorescent dye labeled nucleotide (usually Cy3 or Cy5 la-
beled dCTP or dTTP) to the RT reaction and the cDNA will 
be labeled directly. But in most cases, high amount of starting 
RNA is needed for this method. However, in many cases the 
amount of available biological sample (e.g., FACS cells, laser 
micro-dissected tissue sample or in experimental systems 
where 1000-5000 cells are the subject of the investigation) is 
a limiting factor or the homogeneity of the sample is a serious 
issue. To override these problems, the starting material should 
be amplified, but it is crucial to keep the quantitative ratio 
presented in the original RNA population. The proper use 
of exponential (PCR) and linear (in vitro transcription, IVT) 
amplification can solve this problem (Puskás et al. 2002a, 
2002b; Kitajka et al. 2002). PCR exponentially amplify the 
cDNA but there is a risk of distortion of the original quantity 
ratio. During IVT, the RT reaction is carried out by a specific 
primer containing T7 polymerase binding site so the double 
stranded cDNA can serve as template for the IVT reaction and 
the RNA population can be linearly amplified. In this case, 
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the fluorescent labeled nucleotide is part of the IVT reaction. 
Nowadays, the linear amplification methods are widely spread 
because of their better reproducibility.
It is very important to use the suitable fluorescent dyes 
for labeling. In a typical microarray experiment, the most fre-
quently used fluorescent dyes are the cyanine based Cy3 and 
Cy5. Cy3 and Cy5 are synthetic dye belonging to polymethine 
group. Cy3 is fluorescent in green (~550 nm excitation, ~570 
nm emission), while Cy5 is fluorescent in the red region (~650 
excitation, 670 nm emission). These dyes should meet some 
important criteria, they should be spectrally well separated, 
fluoresce brightly when dry, which simplifies image acquisi-
tion, and should be incorporated with high specific activities 
with a variety of enzymes (Eisen and Brown 1999). There is 
an important disadvantage of Cy5 that should be considered 
during experiment design. It sometimes gives higher back-
ground levels on glass surfaces and is more sensitive to pho-
tobleaching than Cy3 (photobleaching is caused by intense 
light and occurs because the excited state of a molecule is 
generally much more chemically reactive than the ground 
state (van Hal et al. 2000). Different label incorporation ef-
ficiency and scanning artifacts may result in different Cy3- 
and Cy5 fluorescence intensities even when equal amounts 
of Cy3- and Cy5-labeled probes are present. Therefore it is 
essential to properly normalize the fluorescence signals, so 
these types of systematic errors can be kept to a minimum 
increasing microarray data quality (Bilban 2002).
When we compare two transcriptomes there are two op-
tions: using co-hybridization strategy with Cy5-labeled cDNA 
from the test sample and Cy3-labeled cDNA from the control 
sample (Fig. 1), or apply the same fluorescent dye for the 
comparable samples and hybridize them onto different DNA 
chip. As it is mentioned earlier, Cy3 and Cy5 dyes have dif-
ferent fluorescent properties which can be easily differentiated 
(non-overlapping emission and absorption spectra). In the first 
case labeled nucleic acid molecules compete with each other 
for the binding sites on the surface. The hybridization step be-
tween the labeled sample(s) and the immobilized probes car-
ried out for 6-16 hours under specified conditions: usually at 
50-65 ºC, in 10-200 µl of special buffer solution and in special 
metal or plastic chambers under glass coverslip. In most of the 
cases the chambers are put into a rotator in order to provide 
even dispersion. The hybridization temperature depends on 
the binding capacity of complementary nucleotides: in the 
case of 20-40 nt long oligonucleotides, lower temperature 
needs to be applied (37-45 °C), while longer complementary 
nucleotides need higher temperature (45-60 °C) to achieve 
higher stringency and more reliable data. Both the correct 
Figure 1. Diagram of a typical dual-color labeling and hybridization strategy. It is applicable both genomic DNA and mRNA labeling. Genome 
or transcriptome profile of treated/non-treated, healthy/diseased, two different tissues or organisms can be compared in one experiment. 
Genes active only or mainly in the sample A represented by red spots, genes expressed exclusively in sample B represented by green spots, 




choice of hybridization temperature and the stringency of 
the washing step after the hybridization ensure us to get rid 
of signals from weaker or unspecific binding. 
Laser scanner to detect fluorescent signal
The specific fluorescent intensities bound to the surface 
can be captured by a high resolution (usually 2-10 micron) 
fluorescent laser scanner. The scanner generates 1-3 pictures 
files according to the number of applied dyes and experiment 
strategy. The analysis of the spots is made by special software. 
In every spot, the dye intensities correlate to the quantity of 
the bound and hybridized dye. Usually DNA miroarray laser 
scanners possess two lasers: one excites Cy3, the other excites 
Cy5 fluorescent dyes. Thus, the fluorescent intensity in case 
of a gene-expression experiment, is directly proportional to 
the given gene product, i.e. the RNA molecules, which is 
directly proportional to the activity of the gene. During the 
analyses, many correction factors should be applied includ-
ing: the intensity of the local background, the uniformity of 
the spot, any spotting problems, outlier spots, normalization, 
etc. Usually the special analysis softwares incorporate all the 
algorithms need to be applied to get reliable data. 
Bioinformatics
One of the advantages of the microarray approach compared 
to other classic high throughput methods is the close proxim-
ity of the immobilized probes on the surface. This fact opens 
the door to a high numbers of uniform measurements under 
the exact same circumstances. Thus, results from different 
spots can be more comparable and the conclusions are more 
accurate. Besides, local distortions can easily change the in-
tensities and cause low rate error. Since a typical microarray 
contains 10 or 20 thousands spots, this law rate error still can 
generate hundreds of false negative or false positive results. 
In order to eliminate these errors, different softwares and 
statistical methods should be used during the data analysis. 
In different phases of an experiment, numerous errors can 
affect the results and the final output such as: the applied 
technology, laboratory protocols or human error. Theo-
retically, measurement errors and biological variance can be 
separated from each other. Applying different normalization 
methods the measurement errors can be minimalized. There 
are two parts of the measurement error: first is the systematic 
error causing more or less standard measurement deviation 
(e.g., Cy3/Cy5 efficiency distortions) and the second one the 
random deviation. By doing several repeats of an experiment 
the measurement errors can be reduced to the minimum. The 
global normalization methods are suitable for scaling the 
expression vectors. Two commonly used types of normal-
ization exist: (i) one is based on the total intensity and (ii) 
the second is the regression based Lowess corrected median 
normalization (Berger et al. 2004). In the first case, all the 
spot intensities are divided by the sum of the total intensities 
on the array. This method is based on the assumption, that 
the RNA quantity is constant under the analyzed conditions. 
Lowess normalization assumes that the dye bias appears to 
be dependent on spot intensity. In low and high intensity 
range the intensity ratios are distorted due to the inaccurate 
background correction and spot saturation respectively. The 
regression based methods like Lowess normalization are suit-
able for elimination these systematic errors (Fig. 2). In order 
to get reliable data, comprehensive statistical analysis has 
Figure 2. Spots before and after Lowess normalization. In low and high intensity range the intensity ratios are distorted due to the inaccurate 
background correction and spot saturation respectively. The regression based Lowess normalization correct this systematic error.
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also to be performed. Typically both biological and technical 
(dye-swap) replica experiments are carried out to gain data 
for statistical analysis. To find genes with significant expres-
sion differences between two comparable biological samples 
(e.g., diseased versus control samples) Student’s t-test can be 
used, while comparing more than two different conditions 
(e.g., drug concentration, age, sex, control) ANOVA should 
be applied. In microarray data analysis, p-values derived 
from the mentioned statistical tests have to be adjusted by 
multiple testing corrections to correct for occurrence of false 
positives. False positives are the genes that are found to be 
statistically different between conditions, but in fact they 
are not. A typical microarray experiment measures several 
thousand genes simultaneously across different conditions. 
When testing for potential differential expression across those 
conditions, each gene is considered independently from one 
another. In other words, a t-test or ANOVA is performed on 
each gene separately. The incidence of false positives (or 
genes falsely called differentially expressed when they are 
not) is proportional to the number of tests performed and to 
the critical significance level (p-value cutoff). Four types of 
multiple testing corrections are usually used: (i) Bonferroni, 
(ii) Bonferroni Step-down (Holm) (Holm et al. 1979), (iii) 
Westfall and Young Permutation (Westfall et al. 1993), (iv) 
Benjamini and Hochberg False Discovery Rate. The methods 
are listed in order of their stringency, with the Bonferroni be-
ing the most stringent, and the Benjamini and Hochberg FDR 
being the least stringent. The more stringent a multiple testing 
correction is, the less false positive genes are allowed. The 
trade-off of a stringent multiple testing correction is that the 
rate of false negatives (genes that are called non-significant 
when they are) is very high (Benjamini et al. 1995). 
After the several statistical corrections the differently ex-
pressed genes can be further analyzed by the most commonly 
used hierarchical clustering method. This is the most popular 
method for comprehensive gene expression data analysis. 
During clustering, different samples are grouped together into 
clusters based on similarities in their gene expression patterns 
and are connected by a series of branches (clustering tree or 
dendrogram). Experiments with similar expression profiles 
can also be grouped together using the same method. In Fig. 
3, different thyroid diseases are clustered based on their gene 
expression pattern that obtained by microarray experiments. 
Thyroid carcinomas (two malignant and one benign) are 
clearly grouped together while the other diseased samples 
(autoimmune and hormonal diseases) are separated from that 
cluster. Gene expression based clustering methods are very 
important in those cases where no simple methods available 
to separate a disease group from another or from a control 
group. Typical example is the outcome prediction of different 
chemotherapy. In many cancer cases, the treatment is effec-
tive in one patient or patient group but totally ineffective for 
another. Clustering based on differences in gene expression 
fingerprints can be generated which could predict the efficacy 
of the chemotherapy. During clustering, usually marker genes 
or gene groups are looked for that defines a sample cluster. 
To get overall functional information about the significant 
differentially expressed gene set, Gene Ontology (GO) analy-
sis and functional gene clustering are routinely used. To reveal 
significantly enriched biological functions and pathways, 
DAVID bioinformatics system and database (Database for 
Annotation, Visualization and Integrated Discovery, http://
david.abcc.ncifcrf.gov) (Sherman et al. 2007) or other third 
party software like GeneSpring (Agilent) or IPA (Ingenuity 
Pathway Analysis) can be used. These analyses are suitable 
for identifying significantly enriched biological themes, 
particularly GO terms related to multiple genes, discover 
enriched functional-related gene groups in a particular gene 
set comparing to a background set of genes. In order to gain 
information about the possible common regulatory elements 
of differentially expressed genes, analysis of proximal pro-
moter and distant regulatory element of genes with altered 
expression can also be done. The online system called DiRE 
(Distant Regulatory Elements), based on the Enhancer Iden-
tification (EI) method and determines the chromosomal 
location and functional characteristics of DIREs. It enables 
to analyze complex cooperative activity of different regula-
tory elements like proximal promoters and distant regulatory 
elements such as enhancers, repressors, and silencers. The 
Regulatory Elements (RE) are ranked by their importance and 
occurrence in the input co-expressed gene set (Pennacchio et 
al. 2007; Gotea et al. 2008). To explore possible connections/
interactions between proteins coded by significantly altered 
genes, Ingenuity Pathway analysis platform and STRING 
interaction database online tool (http://string-db.org/) are 
very useful. These databases link proteins based on genomic 
context, experimental evidence, co-expression and data from 
other databases such as PubMed, MINT, KEGG, BIND and 
BioGRID. 
Application of microarrays
Gene expression monitoring, basics and general 
considerations
A primary goal of an expression profiling study is to charac-
terize genes that expressed differentially in two experimental 
groups (Szűcs et al. 2010). The array-based gene expression 
analysis based upon a comparison of expression patterns 
between two samples. Total mRNA from both samples are 
first extracted, purified and then converted to cDNA (Murphy 
et al. 2002). The two cDNAs are then labeled with different 
fluorescent dyes and are hybridized onto probes spotted in 
high density onto the surface of the glass surface. The hy-
bridization signals and intensities are then analyzed and the 
differentially expressed genes are selected in the two analyzed 
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samples. These differences in gene expression are causes or 
consequences of a given disease state, show reactions to a 
drug treatment or to environmental changes, reflect altered 
gene function, elucidate genetic regulation and biological 
pathways underlying specific physiological conditions, refer 
to hosts’ response to pathogenic infections and can be a first 
step in disease diagnosis and drug discovery (Murphy et al. 
2002). These molecular fingerprints can also serve as mark-
ers of a given disease and help subgrouping disease clusters 
according the effectiveness of treatment. Microarray technol-
ogy allows the changes in cells at the gene expression level 
induced by various effects (e.g., pharmaceutical treatment, 
pathological processes) to be traced, new biochemical mark-
ers and genes responsible for pathological phenotype to be 
discovered, drug effects to be followed and the treatment to 
be optimized (Csont et al. 2007; Erdi et al. 2012; Szatmári et 
al. 2014). The differences in gene expression of the treated 
and untreated cells or tissues provide information about the 
regulation of the enzymatic pathways influenced by drugs, 
about the enzymes, transporters playing a role in drug resis-
tance. Identification of gene expression patterns may provide 
vital information for understanding the pathological processes 
and contribute to diagnostic decisions and therapies tailored 
to individual patient.
There are three major groups of tools for studying gene 
expression at the transcript level: (i) hybridization-based tech-
niques, such as Northern blotting, subtractive hybridization, 
DNA microarrays or macroarrays, (ii) PCR-based techniques 
such as differential display and RDA (representational dif-
ference analysis) (iii) Sequence-based techniques such as 
SAGE (serial analysis of gene expression) and new generation 
sequencing protocols (NGS) (Kozian et al. 1999)
Northern blot analysis was the first technique that made 
the identification of different mRNA in a given sample pos-
sible. Radiolabeled RNA or DNA probes hybridized to RNA 
fragments separated by gel electrophoresis and immobilized 
onto nylon filter (Alwine et al. 1977). This technique is rarely 
used now, however in some specific projects (e.g., miRNA 
analysis) can be a useful method for detecting transcripts 
or confirming expression data obtained with other experi-
ments although, in this case, big amount of starting material 
(usually 10 µg RNA) is needed to get reliable result. Using 
phosphoimaging, the labeled bands on the membrane can be 
quantified.
Subtractive hybridization was the first technique that en-
abled identification of differentially expressed genes. Subtrac-
Figure 3. Clustering of different thyroid carcinomas by gene expression pattern. Thyroid carcinomas (two malignant and one benign (transpar-




tive cDNA libraries are generated by hybridizing an mRNA 
pool of one origin to an mRNA pool of a different origin 
(Hedrick et al. 1984). Transcripts with no complementary 
strand are then used for cDNA library construction. Despite 
the fact that numerous genes were successfully identified 
with this method, it had serious disadvantages: (i) only small 
fraction of gene expression differences can be successfully 
discovered, (ii) it requires large amount of RNA sample, and 
(iii) quite laborious and time-consuming. 
In 1992, a new PCR-based method called differential 
display PCR (DD-PCR) has been emerged. This technique 
is a one-tube method to compare differentially expressed 
genes systematically (Liang et al. 1992). RNA from two dif-
ferent biological samples is amplified by PCR after a reverse 
transcription (RT), and the generated fragments that reflect 
the expression pattern of the given sample, are separated by 
denaturing gel electrophoresis. Differentially expressed genes 
could be isolated from the gel, sequenced and identified. 
Numerous studies have been published, which - despite the 
serious disadvantages (maintain the quantitative correlation 
after RT and PCR reactions, repeatability, and the elimination 
of false positive signals) - applied this method successfully 
(Prashar et al. 1996; Vogeli-Lange et al. 1996). However, 
this method was almost entirely replaced by new generation 
sequencing technologies.
Serial analysis of gene expression (SAGE) technique 
uses a sequence-based strategy that allows parallel analysis 
of a large number of transcripts (Velculescu et al. 1995). The 
method is based on two principles: (i) a short, 8-9 base pair 
long nucleotide sequence tag contains enough information 
for the identification of the transcript, (ii) concatenation of 
these short tags allows the efficient analysis of transcripts in 
a serial manner by the sequencing of multiple tags within a 
single clone. Results obtained with this technique allow the 
determination of significant quantitative relationship between 
mRNA populations derived from various experimental proce-
dures. This method is much more sensitive in detecting low 
copy number transcripts. The aforementioned techniques are 
material-intensive and time consuming. For these reason, 
efforts had been undertaken to develop methods for high-
throughput screening which are based on new generation 
sequencing technologies. 
DNA microarray technology offers the possibility of 
high-throughput systematic analysis of the transcriptome in 
one experiment. The most informative and probably the most 
important application of DNA chips is the parallel study of 
gene expression from different biological samples focusing 
on the functionally active parts of the genome (DeRisi et al. 
1996; Bittner et al. 2000; Ernst et al. 2002; Stremmel et al. 
2002). DNA microarrays with sets of cDNA fragments or 
gene specific oligonucleotide on their surfaces can be used 
to obtain a molecular fingerprint of gene expression of cells 
in a given time point in a comparative way (Blohm et al. 
2001; Koppler et al. 2002; Lin et al. 2002). Gene expression 
monitoring means quantification of RNA molecules in dif-
ferent conditions of cells or tissue grafts. mRNA population 
of a cell or tissue in a given condition is called transcriptome. 
Differences between transcriptomes due to any genetic or 
environmental factors (e.g., treated cells versus non-treated, 
or diseased state versus control, transgenic plant versus wild 
type) is the most interesting question in biological systems 
and can be answered by one DNA chip experiment. The 
activity (corresponds to mRNA quantity) of nearly 22000 hu-
man genes can be monitored in one hybridization step using 
microarray technology.
The simplest application of the microarrays is the tissue 
specific gene expression analysis. If total RNA extracted from 
a tissue sample is labeled and hybridized onto the surface of 
a DNA microarray, active genes in a given time point can be 
monitored by the analysis and quantification of fluorescent 
spots. For this type of experiment only one fluorescent label-
ing and one hybridization step are needed. More informative 
experiments can be conducted, where two fluorescent dyes are 
applied. These analyses focus on the differences in gene ex-
pression patterns and can be divided to two different groups: 
(i) comparison of expression patterns of two different tissues 
or biological sample (ii) comparison of the same tissue or 
biological sample but at different time point, after different 
treatment or in a different developmental stage.
In the first case, as an example experiment, we can com-
pare the gene activity patterns in leaves and flowers of a 
plant. If the chosen plant in this experiment is Arabidopsis, 
we need Arabidopsis specific DNA microarray to analyze 
specific gene expression profiles. RNA extracted from the two 
different tissues are labeled either Cy5 (red) or Cy3 (green) 
dye, mixed and hybridized onto the Arabidopsis specific DNA 
microarray. On the scanner image red, green and yellow spots 
will represent the relative RNA quantities. The red spots will 
refer to genes active exclusively or mainly in the flower, while 
green spots show the genes active only or mainly in the leaf. 
The yellow spots refer to genes with very similar expression 
level in both tissues. It is understandable even from this very 
simple hypothetical experiment that new and comprehensive 
information about gene activities cannot be gained by any 
other traditional techniques. Genes active only in the flower 
(red spots on the microarray) determine the color, shape, size, 
scent of the flower, while genes responsible for photosynthe-
sis should be looked for among genes expressed exclusively 
in the leaf (green spots).
Comparison of the same tissue or biological sample at 
different time point or after different treatment is the other 
mostly applied experiment types. The “clearest system” for 
this type of experiments is when different states of cell cul-
tures induced by any physical or chemical stress are analyzed. 
In spite of the advantageous homogeneity of the biological 
sample (in most cases contains only one type of cell), one of 
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the major disadvantage of this system that it does not reflect 
the complexity of a living organism. Thus, complex diseases 
cannot be modeled properly in an in vitro system. Analyzing 
a complex system (e.g., post mortem human samples, surgical 
tissue biopsies) however needs careful sample preparation, the 
more homogenous and more precisely dissected the samples 
are the more accurate the result will be. Non-homogeneity 
in the samples can be misleading since results will reflect 
not only the disease state but also the gene expression differ-
ences within the tissue sample deriving from different cell 
type composition. Pooling the samples is a good strategy to 
reduce this type of error to the minimum. Pooling samples 
is very effective for example when samples from organisms 
with different genetic backgrounds are analyzed and common 
gene expression markers are looked for (Zvara et al. 2005; 
Virok et al. 2011). 
In order to predict a disease outcome, exact subtyping of 
the samples is crucial. One of the most common cancer types 
in human is the malignant neoplastic changes in the skin. In 
spite of big efforts, no accepted histopathological or immu-
nohistochemical prediction markers defining subset of mela-
noma according the outcome were found until the develop-
ment of high throughput molecular methods. DNA microarray 
technology had a huge impact on molecular classification of 
melanomas. Bittner et al. (2000) discovered a subset of mela-
noma classified by mathematical analysis of gene expression 
in a series of samples. They showed that melanoma is a useful 
model to identify genes critical for aspects of the metastatic 
process including tumor cell motility.
Identification of new molecular markers based on gene 
expression profiling provides vital information for possible 
future drug development projects or for tailored or per-
sonalized medicine. In case of a complex neuropsychiatric 
disorder, like schizophrenia, the current diagnosis is based 
on complex clinical symptoms existing for more than six 
months. In these cases, the use of easily detectable peripheral 
molecular markers could substantially help to improve and 
speed up the diagnosis the disorders. Screening the periph-
eral blood lymphocytes (PBL) of 13 drug-naive/drug-free 
schizophrenic patients, Zvara et al. (2005) found two marker 
genes (dopamine receptor D2 and the inwardly rectifying 
potassium channel Kir2.3) to be overexpressed in a microar-
ray experiment. The increased mRNA levels were confirmed 
either TaqMan or SybrGreen based quantitative real-time 
PCR (QRT-PCR). The use of molecular markers provides 
more rapid and precise opportunity to diagnose and predict 
an outcome or a drug response of a certain disease. It can help 
to find the optimal medication for the patients.
Microarray technology also provides a good possibility to 
follow a precisely regulated biological process in a compre-
hensive way. As an example, high density cDNA microarray 
was used to get a global picture of gene expression profiles 
during pear fruit development and climacteric ripening. 
These are complex processes involving major changes in 
fruit metabolism (Fischer et al. 1991). Biochemical processes 
occur in a well-defined order under the control of a large set 
of ripening-specific genes leading to changes in texture, pig-
mentation, taste and aroma. Fonseca et al. (2004) analyzed 
a series of fruit samples at different time points of ripening 
process and compare it to fruit that failed to ripe (FR) due 
to precocious harvesting. They found different transcripts 
correspond to kinases and phosphatases were induced spe-
cifically during early developmental stages of pear fruit. 
While another set of genes (transcripts encoding for cell wall 
modifications, and pigment and aroma biosynthesis) were 
activated at the onset of the climacteric period when fruit 
softening rates also increased. Some transcripts putatively 
involved in defense response, oxidative stress, primary and 
secondary metabolism, signaling and transcription regulation 
were also detected. Better understanding the ripening process 
in fleshy fruit is a prerequisite for improving fruit quality and 
storage potential.
Environmental changes (biotic or abiotic, internal or 
external) significantly alter gene expression profile of a bio-
logical system. By tracking those changes, we can reveal the 
molecular and biochemical background, and mechanism of 
action of a drug or a biologically active molecule. Kitajka et 
al. (2004) studied brain gene-expression changes in response 
to different polyunsaturated fatty acids (PUFA) -enriched 
diets in rats with high-density microarrays. PUFAs are well-
known essential structural components of the central nervous 
with a role of controlling learning and memory. In aged rats 
fed throughout life with PUFA-enriched diets, transthyretin, 
alpha-synuclein, and calmodulins were found to have altered 
expression. These genes play important role in synaptic plas-
ticity and learning. It was also shown that omega-3-deficient 
diets during the perinatal period cause altered gene function 
in the offspring throughout their lifetime. They concluded that 
PUFA-enriched diets lead to significant changes in expres-
sion of several genes in the central nervous tissue, and these 
effects appear to be mainly independent of their effects on 
membrane composition.
Detection of chromosomal alterations with oligonucleotide 
arrays
Genetic research has been revolutionized with the develop-
ment of high-throughput genome analysis tools which allow 
simultaneous analysis of many genomic regions. Chromo-
somal alterations in the cancer genome are quite frequent. 
These differences include single nucleotide polymorphisms 
(SNPs one nucleotide mismatch) and copy number variations 
(CNVs) described as genomic fragments ranged in size from 
100 base pairs to 1 kilobase or more (The 1000 Genomes 
Project Consortium 2010; Boone et al. 2010). CNVs usually 
result from structural genomic alterations such as a deletion 
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(loss), duplication (gain), an insertion (usually a gain) or 
unbalanced translocations/inversions that may lead to either 
loss or gain of sequences near the breakpoints (Feuk et al. 
2006). Abnormal copy numbers of these regions have been 
implicated with several diseases and complex traits in human 
and other animals such as in HIV/AIDs susceptibility (Gon-
zalez et al. 2005), autoimmune disease (Fanciulli et al. 2007; 
McKinney et al. 2008), asthma (Brasch-Andersen et al. 2004), 
Crohn’s disease (McCarroll et al. 2008), Osteoporosis (Yang 
et al. 2008). High-resolution microarray-based CNV analysis 
is one of the novel and quick way to detect these copy number 
gains and losses throughout the genome (Shaikh et al. 2007; 
Miller et al. 2010). In contrast to traditionally techniques like 
fluorescence in situ hybridization (FISH), the high resolution 
array-based technologies offers robust methods for genome 
wide search of CNVs with higher resolution and speed (Car-
son et al. 2006). It opens new insight into microdeletions 
and microduplications detection as well as uncovering novel 
CNVs that are undetectable by standard karyotype analysis or 
fluorescence in situ hybridization (Shaikh et al. 2007). 
There are two very efficient types of microarrays ex-
periment that typically used for CNV monitoring: either 
array-based comparative genomic hybridization (aCGH) or 
SNP-based microarrays (SNP-arrays) (Pinto et al. 2011). 
Several factors need to be considered in order to apply the 
most suitable detection system, including resolution desired 
and ability to customize probe content. One of the most im-
portant field the SNP arrays have been used is the mapping 
of human disease susceptibility loci as published in genome-
wide-association studies (GWAS) (Hindorff et al. 2009). In 
order to facilitate the GWAS, a detailed human haplotype map 
has been created using over a million SNP (The International 
HapMap Consortium 2005). High-density SNP arrays contain 
oligonucleotide probes spotted systematically to detect the 
two alleles of a specific SNP locus, in which both the homozy-
gous and heterozygous genotypes could be detected.
Array-based comparative genomic hybridization (aCGH) 
is a rapid method to monitor major DNA copy number chang-
es like deletions or amplifications and provide more accurate 
information about chromosomal imbalances (Houldsworth 
et al. 1994). 
DNA copy number profiling by microarrays often applied 
in tumor genomic researches since specific rearrangements 
usually are characteristic to the individual tumor types and 
states. aCGH provides a lot of information about genomic 
balance of tumor cells, mono- or trisomies, amplifications 
and deletions in a simple experiment. In different cancer 
types, changes within the chromosome like short deletions, 
insertions or amplifications are quite frequent (Mitelman et 
al. 1997). Specific DNA segments containing tumor sup-
pressors (deletions) or oncogenic element (insertions) can 
be revealed using CGH. Genes mapped to the locations of 
these rearrangements can play roles in the formation of tumor. 
Their investigation can contribute to the characterization of 
the different tumors and tumor stages. To detect these chro-
mosomal abnormalities, genomic DNA (gDNA) from tissue 
samples should be purified and analyzed. In this case, not the 
transcriptome but the whole genome is under investigation. 
(Alkan et al. 2011). aCGH uses similar labeling strategy as 
gene expression profiling, DNA from the two samples fluo-
rescently labeled with Cy5 or Cy3 dye, denatured and hybrid-
ized together onto a DNA chip containing high number of 
genomic DNA fragments or oligonucleotides complementary 
to specific regions of already identified genes. After reading 
with a confocal laser scanner, differences in color can be 
measured and analyzed with computer software; differences 
of fluorescent intensities in a spot (mainly red or mainly green 
spots) refer to altered DNA copy numbers between the two 
compared samples. The ratio of signal intensity between the 
test sample and the control is used to determine the copy num-
ber changes at specific genomic locations. The results can be 
easily analyzed with the help of currently available databases 
that contain significant amount of information about the chro-
mosomal location of the genes identified in the experiments. 
Great advantage of these experiments that good quality of 
labeled probe can be obtained even from small amount of 
paraffin archived material. In contrast to conventional CGH 
(uses metaphase chromosomes), aCGH applies probes that 
immobilized onto a solid surface to hybridize to the labeled 
test and control DNAs. These probes can vary in size from 
small oligonucleotides (25-85 base pairs) to genomic clones 
such as bacterial artificial chromsomes (80,000-200,000 base 
pairs). aCGH technique has been applied to create compre-
hensive maps of human CNVs (Iafrate et al. 2004; Redon et 
al. 2006; Wong et al. 2007) 
The initial study of aCGH was from Pinkel et al. (1998). 
They immobilized bacterium artificial chromosomes (BAC) 
and genomic fragments from human chromosome 20 on 
glass surface and demonstrated the feasibility of detecting 
both gains and losses with single copy sensitivity. In spite 
that aCGH is not suitable for identification of small muta-
tions (SNPs or deletions/amplifications of few nucleotides 
within genes), it is extremely useful, well applicable high 
throughput way for the overall analysis of the whole genome. 
It has the significant advantage of being less sensitive to cell 
contaminations. A single gene-copy change may be detected 
from a sample containing up to 60% of normal, healthy cell 
contamination (Hodgson et al. 2001). In case of adult T-cell 
leukemia, both deletion and amplification were successfully 
determined by this method. Testing of 64 patients showed 
amplification in 14q, 7q, and 3q chromosome regions, while 
in the regions 6q and 13q, deletions were observed. These 
chromosome changes were much more frequent in patients 
with aggressive form of leukemia than in indolent form. An 
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increased number of chromosome imbalances were detected 
in patients, where the chance of survival was significantly 
lower (Tsukasaki et al. 2001). 
Fehér et al. (2012) also used aCGH to identify gene copy 
number alterations predictive of metastatic potential or ag-
gressive transformation in papillary thyroid carcinoma (PTC) 
which is the most common well-differentiated thyroid cancer. 
The authors analyzed formalin-fixed and paraffin-embedded 
samples from primary tumors without metastasis, cases with 
only regional lymph node metastasis, and cases with distant 
metastasis, recurrence or extrathyroid extension (a total of 43 
PTC cases). Deletion of the EIF4EBP3 and TRAK2 gene loci 
and amplification of thymosin beta 10 (TB10) and Tre-2 onco-
gene regions were observed as general markers for PTC. Their 
study was the first to report TB10 as a specific marker that 
revealed by genomic amplification. They further revealed that 
the A-kinase anchor protein 13 (AKAP13) gene region was 
discriminative markers for metastasis. The article suggests 
AKAP13 and TB10 regions as potential new genomic markers 
for PTC and cancer progression (Fehér et al. 2012). 
Bonnet et al. (2012) showed a very nice example of CHG 
application for prediction of metastatic event in breast cancer. 
They performed a comparative genomic hybridization study 
on BAC arrays and analyzed 45 patients with metastatic re-
lapse and 95 patients without any recurrence after at least 11 
years of follow-up. Using the array-CGH data, the authors 
established a two-parameter index representative of the global 
level of aneusomy by chromosomal arm, and of the number of 
breakpoints throughout the genome. This genomic instability 
index (G2I) with appropriate thresholds applied in the study 
allowed to distinguish three classes of tumors highly associ-
ated with metastatic relapse. 
Methylation pattern analysis
Environmental factors have major contribution to the devel-
opment of complex diseases like psychological disorders 
(schizophrenia, major depression) through induction of epi-
genetic modifications, such as DNA methylation. Epigenetics 
is one of the most expanding fields in biology, which refers 
to any process that alters gene activity without changing the 
actual DNA sequence and leads to regulation of gene expres-
sion. Changes in methylation pattern usually generate altera-
tions in gene expression programs. Approximately 60-70% 
of all human gene promoters overlap with CpG islands (these 
regions has an elevated GC content and a high frequency of 
CpG dinucleotide). Gene silencing by DNA methylation of 
specific gene promoters is a well-known feature of neoplastic 
cells and plays an important role in normal cell differentiation 
and development. Aberrant DNA methylation pattern of CpG 
islands is one of the earliest and most common alterations 
in human malignancies (Jones et al. 1996). Tumor cells are 
generally characterized by the hypermethylation of tumor 
suppressor genes and, in contrast, hypomethylation of the 
whole DNA molecule. This general hypomethylation can be 
detected relatively early, before the development of the actual 
tumor. Correlation between hypomethylation and increased 
gene expression can be detected in cases of large number of 
oncogenes (Eads et al. 2000; Esteller et al. 2001). Without 
changing the primary DNA sequences, DNA methylation 
occurs mainly at CpG dinucleotide and involves the enzy-
matic addition of a methyl group to the cytosine residue. 
Such modifications at regulatory regions (in particular gene 
promoters), correlate well with the transcriptional state of a 
gene: DNA methylation represses transcription while DNA 
unmethylation can lead to increased transcription levels. 
While DNA methylation is an essential mechanism for 
normal cellular development, imprinting, X-chromosome 
inactivation, and maintaining tissue specificity it can also 
significantly contribute to the progression of various human 
diseases (Esteller 2007). 
Microarray technology is a very effective and high 
throughput way for genome-wide analysis of methylation, 
since in one experiment ten or hundred thousands of distinct 
and identified potential methylation sites can be monitored 
(Adorján et al. 2002). Analysis of genome wide methylation 
profile enables to characterize new tumor classes, or to cluster 
newly diagnosed cases into already existing groups based 
on methylation pattern. In recent years a new method had 
emerged for the analysis of methylation pattern extending to 
the whole genome that is suitable for analyzing large number 
of genes simultaneously (Toyota et al. 1999; Gitan et al. 2001; 
Adorján et al. 2002). The starting biological sample in this 
case is genomic DNA, more precisely the methylated part of 
the gDNA. There are different ways to analyze methylated 
DNA fragments: (i) bisulfide treatment, (ii) methylated DNA 
immunoprecipitation (MeDIP), and (iii) double restriction 
enzymatic DNA cleavage. 
Sodium bisulfite treatment converts the non-methylated 
cytosine is to uracil, while the methylated cytosine stays 
unaffected during the process. The Illumina Methylation 
Assay is one assay that applies the bisulphite conversion 
technology on a microarray level to generate genome-wide 
methylation data. The assay discriminates between the two 
chemically differentiated loci using two site-specific probes, 
one designed for the methylated locus (M bead type) and 
another for the unmethylated locus (U bead type) (http://
technology.illumina.com/technology/beadarray-technology/
infinium-methylation-assay.html). 
Applying immunoprecipitation, sonicated and denatured 
DNA (fragment size 300-1000bp) first immunoselected by 
an antibody directed against 5-methyl-cytidine than im-
munoprecipitated by Protein A Agarose. After elution and 
precipitation of the pulled-down methylated DNA, whole 




The third technique is based on a double enzymatic DNA 
cleavage followed by QPCR. The DNA samples are digested 
by both a methylation-sensitive enzyme which will digest 
unmethylated and partially methylated DNA (the remaining 
(hyper)-methylated DNA will be detected by real-time PCR) 
and a methylation dependent enzyme, which will preferen-
tially digest methylated DNA (the remaining unmethylated 
DNA will be detected by real-time PCR). Using this technique 
a well-defined selection of DNA segments can be analyzed 
to reveal the affected DNA fragments.
In a comprehensive study, methylation pattern of twenty 
samples of advanced ovarian cancer were profiled by Illumina 
HumanMethylation27 BeadChip technology where 27 578 
CpG sites in >14 000 genes were simultaneous analyzed. The 
goal in this case was to find specific CpG sites that correlated 
with progression-free interval (PFI) after therapy. They found, 
that longer survival was associated with both hypomethylated 
CpG sites (e.g., GREB1, TGIF and TOB1) and hypermethy-
lated ones (e.g., TMCO5, PTPRN and GUCY2C). The af-
fected genes plays role in telomere organization, mesoderm 
development and immune regulation. The author concluded 
that this kind of analysis might be of prognostic value (Bau-
erschlag et al. 2011). 
Devaney and co-workers (2013) systematically analyzed 
the epigenetic defects in prostate cancer (PCa) and tried to 
find DNA methylation-based biomarkers that may be useful 
for the early detection and diagnosis of PCa. In their study, 
methylation status of 485 577 CpG sites from regions with a 
broad spectrum of CpG densities were examined by Illumina 
450K methylation platform. They found numerous candi-
date novel genes (BNC1, FZD1, RPL39L, SYN2, LMX1B, 
CXXC5, ZNF783 and CYB5R2) that are frequently methy-
lated and whose methylation was associated with inactivation 
of gene expression in PCa cell lines (Devaney et al. 2013). 
Conclusions
Achievements in the automation technologies, miniaturiza-
tion, new solid surfaces, fluorescent labeling and detection 
systems and the expanding sequence data bases made the 
development of the DNA microarray technology possible. 
According to many concurrent opinions, DNA microarray 
technology is as huge step in molecular biology as the de-
velopment of semiconductor chips was in microelectronics. 
In both cases, the revolutionary change was the incredible 
increase of the number of operations per unit of time (in the 
case of DNA chips the individual hybridizations and specific 
sequence detection). Although the many advantage of this 
technology have been discussed in this review, there are 
some issues to consider and some main pitfalls to carefully 
think over: 
General
A gene-expression experiment reveals the active part of the 
genome but give no information how it is reflected at the 
protein level (there does not necessarily have to be a tight 
correlation between the expression of a gene and the amount 
of translated protein). Microarrays only present a snapshot 
of an actual transcriptome in the cell which is continuously 
changing as the cell responds to cellular and environmental 
signals. Interplay between genes or groups of genes (i.e. 
mechanisms) cannot be easily decoded. Other methods and 
experimental tools are needed to illuminate the proteome, 
understand the varying interactions between genes, and get 
a more complete picture of cellular behavior. Interpretation 
of the results is usually hard and the relationships are often 
difficult to decipher
Experiment design
The goals of the experiment have to be carefully determined. 
We have to choose the most relevant biological comparisons, 
taking into account the various sources of variability, choose 
the most suitable platform, and consider what controls need 
to be used (internal controls and external controls). Generally, 
incorporating replicates in experiment design (technical and 
biological) to generate statistical significance and pooling 
samples to reduce inherent variation are need to be parts of 
the design. Technical replicates aim to eliminate procedural 
variations such as sample preparation and handling, while 
biological replicates aim to identify variation in the biological 
system being studied. 
Samples requirements
Growing, collecting and preparing biological samples, isolat-
ing and purifying RNA are crucial. The tissue samples usually 
have to be processed rapidly to maintain RNA integrity (use 
of RNA stabilizing solution like RNAlater® (Life Technolo-
gies) can resolve this problem). Quality and the amount of 
RNA is a major challenge, the quality of purified RNA 
should be carefully verified (determining the RNA Integrity 
Number (RIN) using Agilent Bioanalyzer system is a good 
choice to check RNA quality). False microarray data can be 
generated from degraded mRNA. Working with small sample 
size (laser dissection or biopsy) can be a difficulty (special 
amplification steps or labeling protocols should be applied). 
The amplification techniques should be selected carefully 
because it can distort the results particularly when multiple 
amplification steps needed. Heterogeneity of most of the 
biological samples, typically tumor samples is also a pitfall 




When cDNA microarrays applied, cross-hybridization can 
cause false positive or false negative results. Using oligo-
nucleotide DNA chips, products of low activity genes often 
enable to be detected, or only with high variance (sensitivity 
issue). The number of false results is bigger in the case of hy-
bridization techniques that use RNA probes because the exact 
circumstances and energetics of DNA-RNA hybridization is 
not precisely known. It is especially true when one-nucleotide 
changes are detected. In case of in situ prepared DNA chips, 
oligonucleotides in one spot are usually mixed because of 
the inefficiency of the coupling. The applied fluorescent dyes 
(Cy3 and Cy5) have different spectral and chemical features 
(quenching, absorbance, acid and ozone sensitivity). This 
often results false data. Color flip or dye flip experiments (la-
beling both the control and the sample nucleic acids with both 
of the dyes) are usually applied to avoid this distortion. 
Reproducibility and standardization
There are multiple sources of variability in a microarray ex-
periment: arrays, dye labeling, efficiency in reverse transcrip-
tion, and hybridization. Since there are numerous error-prone 
steps in a microarray experiments, the procedures need to be 
replicated in order to eliminate sources of error. Standardiza-
tion of protocols and validation of current profiles will have 
to ensure that gene-expression profiles are reliable and repro-
ducible. It is essential, therefore, that experiments are tightly 
regulated and quality controlled. All results should be vali-
dated by independent methods (quantitative PCR, digital PCR 
or Western blot). There is a standard for reporting microarray 
experiments called Minimum Information About a Microarray 
Experiment (MIAME) created by Functional Genomics Data 
Society which specifies a series of standards on collecting and 
analyzing microarray data (raw data, normalized data, sample 
annotation, expreimental design, microarray annotation, data 
processing protocols). This document is designed to allow 
data generated by microarray experiments to be interpreted 
and reproduced with certainty. There are two big repositories 
such as the Gene Expression Omnibus (GEO) created by the 
National Center for Biotechnology Information (NCBI) and 
ArrayExpress created by the EBI to store and share gene 
expression data compiled according MIAME standards.
Bioinformatics
The application of the right biostatistical methods is a key 
element of the procedure. Usually analysis of such a large 
quantities of data generated from microarray tests predispose 
the results to misinterpretation. Without careful selection of 
statistical and normalization methods, hundreds of false data 
can be produced. It is important to consider, that although the 
threshold of the expression change is usually 2-fold, genes 
with lower expression ratio can have serious biological ef-
fects. Multiple professional data analysis software is neces-
sary to extract the results.
Although DNA microarray technology was only devel-
oped a little bit more than two decades ago, nowadays it is 
wildly spread and applied in almost all the fields of biology 
and medicine including oncology, microbiology, neurol-
ogy, developmental biology, psychiatry, diagnostic, forensic 
medicine and it is the basis of new comprehensive disciplines: 
functional genomics, toxicogenomics, and pharmacogenom-
ics. The information value of microarray experiment data 
is unquestionable: discovery new biochemical pathways, 
identification of genes coding for drug resistance, responsible 
or predispose for diseases, identification of disease specific 
molecular genetic markers, analysis of the effects of abiotic 
or biotic stress, display genetic elements of embryogenesis, 
revealing molecular genetic background of genetically modi-
fied organisms. 
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